StonvexLoading…
StonvexStonvexStonvexCore line items from CBAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $41.72M | $44.89M | $35.52M | $109.25M | $72.36M |
Operating Income | Not available | $10.47M | $8.28M | $25.58M | $18.30M |
Net Income | Not available | $8.20M | $6.61M | $20.41M | $14.59M |
EPS (Diluted) | $0.50 | $0.39 | $0.38 | $1.17 | $0.83 |
Total Assets | Not available | $3.72B | $3.74B | $3.15B | $3.12B |
Total Liabilities | Not available | $3.34B | $3.36B | $2.85B | $2.82B |
Cash & Equivalents | Not available | $295.81M | $257.64M | $199.97M | $112.14M |
Free Cash Flow OCF − CapEx | Not available | $53.83M | $-6.90M | $47.42M | $33.36M |
Shares Outstanding | Not available | 21.16M | 21.25M | 17.46M | 17.42M |